While the RAC panel applauded an increase in the number of
treatment studies funded by the Department of Defense's Congressionally Directed Medical Research Program, it expressed grave concerns about a lack of research on other health problems and mortality among Gulf War veterans.
Not exact matches
The company is chasing an at least $ 80 million IPO to help
fund the phase 3
studies that would be necessary for the Food and Drug Administration (FDA) to clear the
treatment (the company has made modifications to the experimental, once - a-day pill that fights brain plaque buildup associated with Alzheimer's).
The
study is patient -
funded; participants, who range in age from late 30s through 80s, must pay $ 8,000 to take part, and live in or travel to Monterey for
treatments and follow - up assessments.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in
treatment duration; availability of
funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical
studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
For the purposes of this economic evaluation, the forms were initially used in a related
study funded by the National Institute of Health Research (NIHR) research for patient benefit programme «assessing the impact of a new birth centre on choice and outcome of maternity care in an inner city area,» which will be reported in full elsewhere, comparing the costs of care in a free standing midwifery unit with care in an obstetric unit in the same trust.16 The data collected included details of staffing levels,
treatments, surgeries, diagnostic imaging tests, scans, drugs, and other resource inputs associated with each stage of the pathway through intrapartum and after birth care.
less than or equal to lamivudine Acquired Immune Deficiency Syndrome Antiretroviral therapy, usually means 1 - 2 drugs, used in early
studies Antiretroviral zidovudine (also known as ZDV) Breastfeeding Baby Friendly Hospital Initiative Breastfeeding and HIV International Transmission
Study Combined antiretroviral therapy Centers for Disease Control and Prevention Deoxyribonucleic Acid Exclusive Breastfeeding Enzyme Linked Immunosorbent Assay Food and Agrigulture Organization Fixed dose combination ART, e.g., lamividine, stavudine, and nevirapine Highly Active Antiretroviral Therapy, 3 or more drugs for more effective
treatment used in later
studies Human Immunodeficiency virus International Atomic Energy Agency Infant feeding Infant and young child feeding Lopinavir cubic millimetre Mother - to - Child Transmission of HIV Non-governmental organization Nevirapine Polymerase Chain Reaction People Living with HIV Prevention of Mother - to - Child Transmission Replacement Feeding Ritonavir Ribonucleic acid, one of the three major macromolecules (along with DNA and proteins) that are essential for all known forms of life single dose NVP United Nations Agencies Joint United Nations Programme on HIV / AIDS United Nations Population
Fund United Nations Commissioner for Refugees United Nations Children's
Fund U.S. Agency for International Development World Alliance for Breastfeeding Action United Nations World Food Programme World Health Assembly WHO 2010 Guidelines on HIV and infant feeding World Health Organization Zidovudine (same drug as AZT)
Senator Betty Little of Queensbury, who helped organize the forum, said the state legislature will create a task force to
study tick - borne illness, and that she believes legislation should be passed to introduce more
funding for disease research, and to require health insurance companies to cover
treatments associated with symptoms of Lyme and other diseases.
The National
Treatment Improvement Evaluation Study (NTIES), a Congressionally - mandated five - year study, found that whereas many clients served by federally - funded programs cut their drug use in half up to a year after treatment, many eventually
Treatment Improvement Evaluation
Study (NTIES), a Congressionally - mandated five - year study, found that whereas many clients served by federally - funded programs cut their drug use in half up to a year after treatment, many eventually rela
Study (NTIES), a Congressionally - mandated five - year
study, found that whereas many clients served by federally - funded programs cut their drug use in half up to a year after treatment, many eventually rela
study, found that whereas many clients served by federally -
funded programs cut their drug use in half up to a year after
treatment, many eventually
treatment, many eventually relapsed.
The
study was published by the Substance Abuse Research and
Treatment journal and was
funded by the Canadian Institutes of Health Research, the McMaster Population Genomics Program and the Peter Boris Centre for Addiction Research.
Cao hopes the
study, which was
funded in part by the National Institute of Mental Health (NIMH), will pioneer future research on details within the hippocampus as a marker for precise diagnosis and positive
treatment response of bipolar disorder.
Animals» presence may ease social anxiety in kids with autism NIH -
funded study could have implications for
treatment
Along these lines, the Department of Defense and National Collegiate Athletic Association (NCAA) plan to launch a $ 30 - million effort to
fund studies on concussion and head - impact exposure among college - age athletes with a multisite longitudinal clinical
study on concussion risks,
treatment and management.
According to a
study funded in part by the National Institutes of Health, companion animals — like dogs, cats or the guinea pigs in the
study — may prove to be a helpful addition to
treatment programs designed to help children with ASDs improve their social skills and interactions with other people.
Since 2006, the number of industry - sponsored clinical trials
studying the benefits and harms of medical
treatments has risen dramatically, while the number of clinical trials
funded by the National Institutes of Health (NIH) has fallen substantially, according to new Johns Hopkins Bloomberg School of Public Health research.
Dr Lee Campbell, Research Projects and Science Communications Manager at Cancer Research Wales, who part -
fund the
study, commented: «This is an exciting breakthrough as cancer stem cells are thought to be responsible for the failure of many cancer
treatments and the re-emergence of cancers, often many years after the initial disease.
Bride and his co-authors analyzed a large, national sample of Substance Use Disorder counselors from the National Institutes of Health -
funded National
Treatment Center
Studies.
This
study was performed in partnership with the POLARIS program, a strategic national program
funded by A * STAR to translate local research findings towards «fit - for purpose» applications that improve the diagnosis and
treatment of diseases in Singapore.
The
study was
funded by HealthTronics, a medical technology company that manufactures the ablation probes used for the
treatment.
Called the Canakinumab Anti-inflammatory Thrombosis Outcomes
Study (CANTOS) and
funded by the drug giant Novartis, the trial also found fewer cases of lung cancer in those on the
treatment, rekindling basic research findings hinting that the same inflammatory pathway may initiate or spur the growth of such tumors.
The new doubts over psoralen stem partly from a
study funded by the Brussels - based European Organization for Research and
Treatment of Cancer.
«
Funding research focused on helping patients survive longer is critical, and
studies such as this advance our goal of not only improving
treatments for brain cancer, but eventually finding a cure.»
The
study was
funded by the King County Wastewater
Treatment Division and the U.S. Environmental Protection Agency.
It was such a significant improvement that the
funding agencies for the
study paid for the 150 lots in the control group to receive the cleaning - and - greening
treatment.
The
study,
funded by a grant from the National Institute on Alcohol Abuse and Alcoholism, followed nearly 300 patients over a six - month period following admission to an outpatient dual - diagnosis
treatment program that provided both substance abuse and mental illness
treatment.
Funded by the National Institute of Mental Health, STAR * D was the largest and longest
study of depression
treatment ever conducted.
«Remarkably little research
funding has been made available to
study the etiology, pathophysiology, and effective
treatment of this disease, especially given the number of people affected,» the authors noted.
Findings from the
Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, have revealed that adding the medication known as spironolactone (Aldactone) to existing therapy did not significantly reduce the composite time to either death from cardiovascular causes, surviving a cardiac arrest, or hospitalization to manage heart failure in patients with heart failure and a preserved ejection fraction in a
study funded by the National Heart, Lung and Blood Institute, National Institutes of Health.
The Myelin Repair Foundation, which
funded this work as part of a multi-institutional effort to accelerate research and development of
treatments for MS, has entered into a cooperative agreement with the National Institutes of Health to assess guanabenz as a therapeutic candidate in MS clinical
studies.
«
Studies like this one help advance our understanding of autism and improve the way scientists and clinicians develop new
treatments,» said Lisa Gilotty, Chief of the Research Program on Autism Spectrum Disorders at the National Institute of Mental Health, one of the agencies that
funded the
study.
This
study was presented at the Featured Clinical Research Session I: Two - year Outcomes of Surgical
Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial from The Cardiothoracic Surgical Trials Network The Moderate Ischemic Mitral Regurgitation trial was supported by a cooperative agreement (U01 HL088942)
funded by the National Heart Lung and Blood Institute, the National Institutes of Neurological Disorders and Stroke of the National Institutes of Health (NIH), Bethesda, MD, and the Canadian Institutes of Health Research.
«Enlarged cysts in kidneys can lead to reduced kidney function and eventually kidney failure, where the only
treatment is dialysis or transplantation,» said
study author Michael Flessner, M.D., Ph.D., a program director at the NIH's National Institute of Diabetes and Digestive and Kidney Diseases, which
funded the trial.
«This
study opens a promising new avenue of research into
treatments that may prevent the development of epilepsy,» said Vicky Whittemore, PhD, a program director at the National Institute of Neurological Disorders and Stroke, who oversees the grants that
funded this
study.
The New EPOC
study, published in The Lancet Oncology and
funded by Cancer Research UK, evaluated whether the drug cetuximab and chemotherapy together worked better than chemotherapy alone as a
treatment in addition to surgery for people with bowel cancer that had spread to the liver but could be surgically removed.
«We really have all the pieces we need to move forward in the development of effective therapeutics,» says Paul Aisen, a neuroscientist at the University of California, San Diego, and director of the Alzheimer's Disease Cooperative
Study — a 21 - year - old programme of government -
funded clinical
studies aimed at developing Alzheimer's
treatments.
Professor Peter Weissberg, Medical Director at the British Heart Foundation, which part -
funded the research, said: «This
study helps us to understand how and why our blood vessels contract and expand, and could help scientists develop
treatments for many conditions where blood vessel or «vascular» health is important, from Raynaud's to heart failure.
It corroborates the findings of another NIAID -
funded study demonstrating that TMP - SMX
treatment resulted in better clinical outcomes than placebo for MRSA skin abscesses, and also upholds other findings that both clindamycin and TMP - SMX are equally beneficial in treating MRSA skin infections.
Her research
studies, investigating the mechanisms of and
treatments for cognitive dysfunction in the setting of epilepsy, have been
funded by federal, foundation, and industry grants.
St. Louis University researchers, through the NIAID -
funded Vaccine and
Treatment Evaluation Units network, will examine the optimal dose of the vaccine to be used in larger
studies.
In collaboration with Shawneequa Callier, J.D., of George Washington University, CRGGH received
funding to
study physicians» assumptions on genetics and race / ethnicity in the
treatment of hypertensive AA on Medicare.
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, which
funded the
study said: «That analysing the architecture of lymph nodes could help predict whose breast cancer is likely to spread, and ultimately help guide
treatment, is a highly exciting prospect.
Los Angeles, CA (NOV 15, 2016)-- More people die from lung cancer every year than any other cancers, and researchers are hard - pressed to find
funding for
studies that could improve
treatments.
November 12, 2013 Kurt + Peter Foundation
funds research into potential
treatment for rare form of muscular dystrophy The Kurt + Peter Foundation has awarded a two - year grant to Elizabeth McNally, MD, PhD, professor of medicine and human genetics at the University of Chicago, to
study a potential
treatment for limb girdle muscular dystrophy, type 2C — a rare but severe form of muscular dystrophy.
• African Cohort
Study (AFRICOS) is a large, long - term cohort study at multiple African sites that will evaluate HIV prevention, care and treatment services it supports through local facilities, funded by the U.S. President's Emergency Plan for AIDS Relief (PE
Study (AFRICOS) is a large, long - term cohort
study at multiple African sites that will evaluate HIV prevention, care and treatment services it supports through local facilities, funded by the U.S. President's Emergency Plan for AIDS Relief (PE
study at multiple African sites that will evaluate HIV prevention, care and
treatment services it supports through local facilities,
funded by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR)
He is currently
funded (2016 - 2021) by the National Cancer Institute to
study radiation induced changes in neuron cell dendritic morphology in cancer
treatment with X-rays, protons and carbon beams, and has received grants from the Department of Energy and NASA in the past.
She is institutional principal investigator of the Phase I Consortium
Study in New Agents in Neuroblastoma
Treatment and directs NIH -
funded work on effects of SPARC (secreted protein acidic and rich in cysteine, an amino acid) on neuroblastoma tumor growth and blood vessel formation.
Children receiving care at Texas Children's Sickle Cell Program have the opportunity to participate in several National Institutes of Health (NIH)-
funded research
studies led by physician scientists, providing the latest
treatments for this disease.
See below for other CRI -
funded studies that are advancing the understanding and
treatment of melanoma.
Monies have gone to
fund such projects as a postdoctoral fellow
studying familial hypercholesterolemia, evaluating the efficacy and safety of a new drug for congenital hyperinsulinism, and identifying molecular targets for Pitt - Hopkins Syndrome
treatments.
The CIRM board also announced the approval of US $ 58.8 million in
funding for five new clinical trials which will
study potential
treatments for a variety of diseases and conditions, namely malignant glioma, acute myeloid leukemic, neutropenia, high - risk type 1 diabetes and kidney disease.
We also performed subgroup meta - analyses by type of prevention (primary v secondary: in this
study, trials involving healthy populations or patients with any specific disease except for cardiovascular disease were classified as primary prevention trials, and trials involving patients with cardiovascular disease were classified as secondary prevention trials), type of supplement by quality and dose (each supplement, vitamins only, antioxidants only, or antioxidants excluding vitamins), type of outcome (cardiovascular death, angina, fatal or non-fatal myocardial infarction, stroke, or transient ischaemic attack), type of outcome in each supplement, type of
study design (randomised, double blind, placebo controlled trial v open label, randomised controlled trial), methodological quality (high v low), duration of
treatment (< 5 years v ≥ 5 years),
funding source (pharmaceutical industry v independent organisation), provider of supplements (pharmaceutical industry v not pharmaceutical industry), type of control (placebo v no placebo), number of participants (≥ 10000 v < 10000), and supplements given singly or in combination with other vitamin or antioxidant supplements by quality.